INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41m ago
HOUSE PTR1m ago
SEC 13F58s ago
ROBINHOOD CHAIN53s ago
Corporate insider
FR

Fenimore Christopher R.

EVP Finance CFOCIK 0001697422

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score26
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Tax withholding
F$4.03M
4,243 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    REGENERON PHARMACEUTICALS, INC.EVP Finance CFO · Aug 20, 2026
12
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Gift
G
—
15 sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

9
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
6,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

26
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.29M
6,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

26
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.40M
6,283 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

26
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Tax withholding
F$3.74M
4,599 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence

9
FR
Fenimore Christopher R.EVP Finance CFO
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
6,283 sh
Aug 18, 2026Aug 20, 2026
traded Aug 18, 2026
+2dSEC FORM 4

Evidence